Clinical Trial Update: Bexarotene Treatment in Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating bexarotene for schizophrenia. The trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN